Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-25 @ 8:09 PM
Study NCT ID:
NCT05983835
Status:
UNKNOWN
Last Update Posted:
2023-08-09
First Post:
2023-08-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study
Sponsor:
Fujian Medical University Union Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-02
First Submit QC Date:
None
Study First Post Date:
2023-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-02
Last Update Post Date:
2023-08-09
Last Update Post Date Type:
ACTUAL